Marc Tischkowitz

Cytowane przez

	Wszystkie	Od 2020
Cytowania	37377	21521
h-indeks	90	68
i10-indeks	247	204

4400

2200

1100

3300

2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025131 135 237 264 381 401 485 547 691 841 1038 1328 1710 1835 2382 2888 3477 4264 4235 4176 4381 935

Dostęp publiczny

Wyświetl wszystko

256 artykułów

12 artykułów

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

William D. FoulkesProfessor of Oncology, Medicine, and Human Genetics. McGill UniversityZweryfikowany adres z mail.mcgill.ca
Douglas EastonProfessor of Genetic Epidemiology, University of CambridgeZweryfikowany adres z medschl.cam.ac.uk
Paul PharoahCedars-Sinai Medical CenterZweryfikowany adres z cshs.org
Evans DG*, Evans G*University of ManchesterZweryfikowany adres z mft.nhs.uk
Clare TurnbullProfessor of Translational Cancer Genetics, Institute of Cancer ResearchZweryfikowany adres z icr.ac.uk
David HuntsmanBC Cancer AgencyZweryfikowany adres z bccancer.bc.ca
Fiona WalterQueen Mary University of LondonZweryfikowany adres z qmul.ac.uk
Mark E. RobsonMemorial Sloan KetteringZweryfikowany adres z mskcc.org
Sean TavtigianProfessor of Oncological Science, University of UtahZweryfikowany adres z hci.utah.edu
Melissa C SoutheyChair Precision Medicine, Monash UniversityZweryfikowany adres z monash.edu
Peter DevileeLeiden University Medical CenterZweryfikowany adres z lumc.nl
Katherine L NathansonProfessor of Medicine, Perelman School of Medicine at the University of PennsylvaniaZweryfikowany adres z upenn.edu
Emma R. WoodwardManchester Centre for Genomic MedicineZweryfikowany adres z mft.nhs.uk
Steven NarodCanada Research Chair in Breast Cancer; Director, Familial Breast Cancer Research Unit, WCRIZweryfikowany adres z wchospital.ca
Georgia Chenevix-TrenchQueensland Institute of Medical ResearchZweryfikowany adres z qimr.edu.au
Chantal Babb de VilliersUniversity of CambridgeZweryfikowany adres z medschl.cam.ac.uk
Patrick ConcannonDepartment of Pathology, Immunology, and Laboratory Medicine, University of FloridaZweryfikowany adres z ufl.edu
Marjanka K SchmidtNetherlands Cancer InstituteZweryfikowany adres z nki.nl
Helmut Hanenberg, MDUniversity Children's Hospital, University of Duisburg-EssenZweryfikowany adres z uni-due.de
Massimiliano di PietroClinician Scientist, Early Cancer Institute, University of CambridgeZweryfikowany adres z cam.ac.uk

Obserwuj

Marc Tischkowitz

University of Cambridge

Zweryfikowany adres z cam.ac.uk - Strona główna

Cancer Genetics DNA repair Cancer Syndromes


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ... Jama 317 (23), 2402-2416, 2017	3178	2017
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non … KA Gelmon, M Tischkowitz, H Mackay, K Swenerton, A Robidoux, ... The lancet oncology 12 (9), 852-861, 2011	1382	2011
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE N Mavaddat, S Peock, D Frost, S Ellis, R Platte, E Fineberg, DG Evans, ... JNCI: Journal of the National Cancer Institute 105 (11), 812-822, 2013	1171	2013
Breast-Cancer Risk in Families with Mutations in PALB2 AC Antoniou, S Casadei, T Heikkinen, D Barrowdale, K Pylkäs, J Roberts, ... New England Journal of Medicine 371 (6), 497-506, 2014	1142	2014
Gene-panel sequencing and the prediction of breast-cancer risk DF Easton, PDP Pharoah, AC Antoniou, M Tischkowitz, SV Tavtigian, ... New England Journal of Medicine 372 (23), 2243-2257, 2015	1083	2015
Prevalence and architecture of de novo mutations in developmental disorders Nature 542 (7642), 433-438, 2017	1026	2017
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer E Castro, C Goh, D Olmos, E Saunders, D Leongamornlert, ... Journal of clinical oncology 31 (14), 1748-1757, 2013	980	2013
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer S Reid, D Schindler, H Hanenberg, K Barker, S Hanks, R Kalb, ... Nature genetics 39 (2), 162-164, 2007	750	2007
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors T Taniguchi, M Tischkowitz, N Ameziane, SV Hodgson, CG Mathew, ... Nature medicine 9 (5), 568-574, 2003	727	2003
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors A Lee, N Mavaddat, AN Wilcox, AP Cunningham, T Carver, S Hartley, ... Genetics in medicine 21 (8), 1708-1718, 2019	693	2019
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers RS van der Post, IP Vogelaar, F Carneiro, P Guilford, D Huntsman, ... Journal of medical genetics 52 (6), 361-374, 2015	673	2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015	589	2015
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ... BMC cancer 7, 1-11, 2007	565	2007
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer P Kaurah, A MacMillan, N Boyd, J Senz, A De Luca, N Chun, G Suriano, ... Jama 297 (21), 2360-2372, 2007	549	2007
Hereditary breast cancer: new genetic developments, new therapeutic avenues PM Campeau, WD Foulkes, MD Tischkowitz Human genetics 124, 31-42, 2008	504	2008
Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type L Witkowski, J Carrot-Zhang, S Albrecht, S Fahiminiya, N Hamel, ... Nature genetics 46 (5), 438-443, 2014	499	2014
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017	467	2017
Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease KJ Carss, G Arno, M Erwood, J Stephens, A Sanchis-Juan, S Hull, K Megy, ... The American Journal of Human Genetics 100 (1), 75-90, 2017	466	2017
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674-685, 2020	443	2020
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017	419	2017

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy